Bethesda, MD, United States of America

Jeffrey Baron

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • North Potomac, MD (US) (2017)
  • Bethesda, MD (US) (2019 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Jeffrey Baron

Introduction

Jeffrey Baron is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies.

Latest Patents

Baron's latest patents focus on monoclonal antibodies that specifically bind to matrilin-3. These patents disclose not only the antibodies and their fragments but also conjugates that include these molecules. Additionally, they cover nucleic acid molecules encoding the antibodies and antigen-binding fragments. The patents also describe compositions that include the disclosed antibodies, fragments, conjugates, and nucleic acid molecules. Furthermore, methods for treating or inhibiting cartilage disorders in subjects are provided, along with techniques for increasing chondrogenesis in cartilage tissue. These methods can be particularly useful for treating growth plate disorders, such as skeletal dysplasia or short stature.

Career Highlights

Jeffrey Baron is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work has led to the advancement of therapeutic strategies aimed at addressing cartilage-related disorders.

Collaborations

Some of his notable coworkers include Crystal Sao Fong Cheung and Julian Chun Kin Lui. Their collaborative efforts contribute to the innovative research being conducted at the National Institutes of Health.

Conclusion

Jeffrey Baron is a distinguished inventor whose work in monoclonal antibodies has the potential to transform treatments for cartilage disorders. His contributions to biomedical research continue to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…